These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 18088079

  • 1. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A, Ishii T, Shimada K, Makondo K, Inanami O, Sakane N, Yoshida T, Saito M, Kimura K.
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
    Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H.
    Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF, De Vriese AS, Tilton RG, Van de Voorde J, Denner L, Lameire NH, Flyvbjerg A.
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [Abstract] [Full Text] [Related]

  • 6. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina.
    Cukiernik M, Hileeto D, Downey D, Evans T, Khan ZA, Karmazyn M, Chakrabarti S.
    Diabetes Metab Res Rev; 2004 Jan; 20(1):61-71. PubMed ID: 14737747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats.
    Lu YL, Hu SJ, Shen ZJ, Shao YC.
    Chin Med J (Engl); 2004 Aug; 117(8):1165-9. PubMed ID: 15361289
    [Abstract] [Full Text] [Related]

  • 10. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
    Wang C, Li J, Lv X, Zhang M, Song Y, Chen L, Liu Y.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):131-7. PubMed ID: 19686728
    [Abstract] [Full Text] [Related]

  • 11. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2005 Mar 12; 20(3):532-8. PubMed ID: 15665028
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
    Casey RG, Joyce M, Roche-Nagle G, Chen G, Bouchier-Hayes D.
    J Surg Res; 2005 Feb 12; 123(2):176-81. PubMed ID: 15680375
    [Abstract] [Full Text] [Related]

  • 14. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study.
    Huang DY, Richter K, Breidenbach A, Vallon V.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan 12; 365(1):67-73. PubMed ID: 11862335
    [Abstract] [Full Text] [Related]

  • 15. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
    Samnegård B, Jacobson SH, Johansson BL, Ekberg K, Isaksson B, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2004 Jun 12; 19(6):1385-91. PubMed ID: 15004258
    [Abstract] [Full Text] [Related]

  • 16. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T, De La Tour DD, Kunt T, Pfützner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Löbig M, Engelbach M, Beyer J, Vague P.
    Clin Sci (Lond); 2000 Mar 12; 98(3):283-90. PubMed ID: 10677386
    [Abstract] [Full Text] [Related]

  • 17. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE.
    Nephrol Dial Transplant; 2008 Apr 12; 23(4):1346-54. PubMed ID: 18065828
    [Abstract] [Full Text] [Related]

  • 18. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.
    Johansson BL, Wahren J, Pernow J.
    Am J Physiol Endocrinol Metab; 2003 Oct 12; 285(4):E864-70. PubMed ID: 12799312
    [Abstract] [Full Text] [Related]

  • 19. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
    Jesmin S, Zaedi S, Maeda S, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 12; 231(6):925-31. PubMed ID: 16741025
    [Abstract] [Full Text] [Related]

  • 20. The relationship between nitric oxide and leptin in the lung of rat with streptozotocin-induced diabetes.
    Oztay F, Kandil A, Gurel E, Ustunova S, Kapucu A, Balci H, Akgun-Dar K, Demirci C.
    Cell Biochem Funct; 2008 Jun 12; 26(2):162-71. PubMed ID: 17542037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.